Class Action

Similac Infant Formulas


Case Name (Date)

Green et al. v. Abbott Laboratories
22-cv-3930, N.D. Cal.
(July 2022)


Product/Service

Similac infant formula powders


Allegations

Products do not contain enough powder to make the advertised number of bottles


Status

Pending



Class-Action Tracker

Glucerna

Class Action

Glucerna

Allegations: Falsely marketing that products are “specifically designed for people with diabetes” and “help manage blood sugar” when they contain ingredients that negatively affect blood sugar levels and gut health

PediaSure Grow & Gain

Class Action

PediaSure Grow & Gain

Allegations: Falsely marketing that products are “clinically proven to help kids grow” when scientific evidence shows such claims are not true


The Latest

Filters